-
Economic evaluation of improving HIV self-testing among MSM in China using a crowdsourced intervention: a cost-effectiveness analysis
Author: Ong, Jason J. J.; Booton, Ross D. D.; Tucker, Joseph D. D.; Tang, Weiming; Vickerman, Peter; Zhang, Lei; Mitchell, Kate M. M.
Journal: AIDS. 2023; Vol. 37, Issue 4, pp. 671-678. DOI: 10.1097/QAD.0000000000003457
-
Factors associated with reduced function and quality of life among adult people with HIV with depression and substance use in the Asia-Pacific region
Author: Rajasuriar, Reena; Chong, Meng Li; Ross, Jeremy; Jiamsakul, Awachana; Avihingsanon, Anchalee; Lee, Man Po; Ditangco, Rossana; Choi, Jun Yong; Gatechompol, Sivaporn; Chan, Iris; Melgar, Maria Isabel Echanis; Kim, Jung Ho H.; Sohn, Annette; Law, Matthew
Journal: AIDS. 2023; Vol. 37, Issue 5, pp. 823-835. DOI: 10.1097/QAD.0000000000003474
-
Longitudinal characterization of circulating extracellular vesicles and small RNA during simian immunodeficiency virus infection and antiretroviral therapy
Author: Huang, Yiyao; Liao, Zhaohao; Dang, Phuong; Queen, Suzanne; Abreu, Celina Monteiro; Gololobova, Olesia; Zheng, Lei; Witwer, Kenneth W.
Journal: AIDS. 2023; Vol. 37, Issue 5, pp. 733-744. DOI: 10.1097/QAD.0000000000003487
-
Structural and functional characterization of HIV-1 cell fusion inhibitor T20.
Author: Zhang X1,2, Ding X1, Zhu Y1, Chong H1, Cui S1, He J2, Wang X3, He Y1,2.
Journal: AIDS. 2019 Jan 27;33(1):1-11. doi: 10.1097/QAD.0000000000001979.
-
Rapid CD4+ T-cell decline is associated with coreceptor switch among MSM primarily infected with HIV-1 CRF01_AE in Northeast China.
Author: Cui H1,2,3, Geng W1,2,3, Sun H1,2,3, Han X1,2,3, An M1,2,3, Jiang Y1,2,3, Zhang Z1,2,3, Chen Z4, Xu J1,2,3, Hu Q1,2,3, Zhao B1,2,3, Zhou B1,2,3, Shang H1,2,3.
Journal: AIDS. 2019 Jan 27;33(1):13-22. doi: 10.1097/QAD.0000000000001981.
-
Increased influenza-specific antibody avidity in HIV-infected women compared with HIV-infected men on antiretroviral therapy.
Author: Luo Z1, Ogunrinde E1, Li M1, Zhang L2, Martin L3, Zhou Z1, Hu Z1,4, Zhang T1,5, Li Z1,6, Zhang J1,7, Su B6, Zhang T6, Wu H6, Ma L8, Liao G8, Eckard AR3,9, Westerink MAJ1,3, Heath SL10, Jiang W1,3.
Journal: AIDS. 2019 Jan 27;33(1):33-44. doi: 10.1097/QAD.0000000000002022.
-
Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized mice.
Author: Ling L1,2, Wu T1, To KKW1, Cheung KW1, Lui KO3, Niu M1, Lam KS1, Wang CC4, Li J3, Wang H2, Yuen KY1, Chen Z1,2.
Journal: AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002149. [Epub ahead of print]
-
Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice.
Author: Ling L1,2, Wu T1, To KKW1, Cheung KW1, Lui KOL3, Niu M1, Lam KS1, Wang CC4, Li J3, Wang H2, Yuen KY1, Chen Z1,2.
Journal: AIDS. 2019 Mar 15;33(4):F1-F12. doi: 10.1097/QAD.0000000000002149.